Brief Article
Copyright ©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Aug 28, 2013; 19(32): 5334-5339
Published online Aug 28, 2013. doi: 10.3748/wjg.v19.i32.5334
Table 1 Prevalence of dysmetabolic diseases and biochemical abnormalities in the total study population n (%)
Patients examinedPositive patients
Hyperlipidemia27151035 (38.1)
Fatty liver2605677 (26.0)
Increased ALT and/or AST levels3393405 (11.9)
Gallstone2605296 (11.4)
HBsAg2244198 (8.8)
Hyperglycemia2767203 (7.3)
Hypertension2938210 (7.3)
Hyperuricemia2700167 (6.2)
Increased Scr levels215010 (6.2)